We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App





Bio-Rad Exhibits Range of Solutions for Maximizing Lab Efficiency at AACC

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: Visitors to the company’s booth at AACC 2022 saw a range of solutions that support labs by maximizing efficiency (Photo courtesy of Bio-Rad)
Image: Visitors to the company’s booth at AACC 2022 saw a range of solutions that support labs by maximizing efficiency (Photo courtesy of Bio-Rad)

At the 2022 AACC Clinical Lab Expo, Bio-Rad Laboratories (Hercules, CA, USA) is presenting its range of solutions that support labs by maximizing efficiency through streamlining workflows, consolidating platforms, improving turnaround time and gaining confidence in results.

Bio-Rad is exhibiting its quality control solutions that help streamline workflows, reduce errors, maintain compliance, and facilitate accreditation—improving efficiency and saving money. These solutions included its InteliQ Load-and-Go Controls that can transform QC workflow with load-and-go-efficiency. InteliQ quality controls, a smarter way to manage QC, help automate workflow - reducing turnaround time, limiting manual errors, and increasing overall efficiency. Bio-Rad will also present its Unity QC Data Management Solutions that help achieve greater efficiency while reducing costs. In addition to identifying trends and making corrections before results are compromised, connectivity to the world’s largest community of QC users brings the confidence and reliability to stand behind the results. Also on display will be the company’s comprehensive line of molecular quality controls, standards, and data management solutions that streamline workflow and set a new standard in molecular lab performance.

Visitors at Bio-Rad’s AACC 2022 booth can experience its D-100 hemoglobin testing system, a fully automated, best-in-class HbA1c analyzer featuring a highly evolved combination of hardware, software and chemistry for high-volume labs, and the BioPlex 2200 System, which consolidates autoimmune, infectious disease, and vitamin D testing all on one fully automated, track line compatible, random-access platform. Also on display at the event will be IH-500, the latest addition to the Bio-Rad IH-Complete family of immunohematology testing systems that delivers an easy-to-use, fully automated system with random access and minimal user intervention. In addition, Bio-Rad is showcasing the IH-Reader 24, a combination centrifuge and reader for convenient and intelligent processing of manually pipetted IH-Gel Cards; the IH-1000 fully automated, walk-away system for ID-Cards with high-throughput, continuous sample and reagent loading; and the IH-Centrifuge L and IH-Incubator L, small but powerful members of the IH-Complete family that allow labs of all sizes to standardize gel and tube applications.
 

Related Links:
Bio-Rad Laboratories 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.